Basit öğe kaydını göster

dc.contributor.authorHaberl, M
dc.contributor.authorAnwald, B
dc.contributor.authorKlein, K
dc.contributor.authorWeil, R
dc.contributor.authorFuss, C
dc.contributor.authorGepdiremen, A
dc.contributor.authorWojnowski, L
dc.date.accessioned2020-06-21T15:30:48Z
dc.date.available2020-06-21T15:30:48Z
dc.date.issued2005
dc.identifier.issn1744-6872
dc.identifier.issn1744-6880
dc.identifier.urihttps://doi.org/10.1097/01.fpc.0000171517.22258.f1
dc.identifier.urihttps://hdl.handle.net/20.500.12712/20968
dc.descriptionZanger, Ulrich M./0000-0002-5276-2002en_US
dc.descriptionWOS: 000231394400002en_US
dc.descriptionPubMed: 16041240en_US
dc.description.abstractThe human cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several xenobiotic compounds of clinical or toxicological importance. We aimed to identify genetic variants and major CYP2A6 haplotypes associated with CYP2A6 phenotypic variation. CYP2A6 mRNA level, protein level, activity and haplotypes were determined in Caucasian liver samples via real-time polymerase chain reaction, Western blot, coumarin 7-hydroxylation, DNA sequencing and genotyping, respectively. Phenotypes were then analyzed for associations with haplotypes. CYP2A6 transcript, protein and activity levels were correlated among each other. In 45 African-American, 156 Caucasian, 47 Chinese, 50 Japanese and 47 Korean DNA samples, we detected 95 different polymorphisms in the CYP2A6 gene, 49 of which had not been described previously. Caucasian variants formed 33 haplotypes which built four clades. Allele *9B and the CYP2A7/2A6 partial deletion allele CYP2A6*12B were both associated with decreased expression. The latter haplotype extends at least over 147 kb up into the CYP2B6 gene. A haplotype almost identical to allele *1A was associated with decreased expression and activity of CYP2A6 compared to all other haplotypes. In summary A CYP2A6* 1A-like allele, *9B and * 12B are major genetic determinants of CYP2A6 phenotype variation in Caucasians.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/01.fpc.0000171517.22258.f1en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcytochrome P450en_US
dc.subjectCYP2A6en_US
dc.subjectgenetic polymorphismen_US
dc.subjecthaplotypeen_US
dc.subjectpharmacogeneticsen_US
dc.titleThree haplotypes associated with CYP2A6 phenotypes in Caucasiansen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume15en_US
dc.identifier.issue9en_US
dc.identifier.startpage609en_US
dc.identifier.endpage624en_US
dc.relation.journalPharmacogenetics and Genomicsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster